3 October 2017

René Marke, PhD candidate at the Laboratory of Pediatric Oncology, theme Cancer development and immune defense, has received the Tom Voûte Young Investigator Award 2017. This price is handed out each year bij Kika (kinderen kankervrij) for excellent research in the area of pediatric oncology.

As part of his thesis work in the group of Frank van Leeuwen, René has been studying role of the lymphoid transcription factor IKZF1 in glucocorticoid therapy resistance in Acute Lymphoblastic Leukemia (ALL). Rene found that loss of IKZF1 function in ALL contributes to glucocorticoid resistance in the patient, which may explain why patients carrying this deletion have a less favorable prognosis. His current research focuses on the mechanisms by which IKZF1 loss leads to glucocorticoid resistance, and the identification of molecular therapies that can improve therapy response is this high risk ALL subgroup.

The jury was impressed by the scientific quality of the work, which was presented by René on 28 September at the annual KiKa science day organized by the Prinses Maxima Center for Pediatric Oncology.

Tom Voûte Young Investigator Award 2017: link


 

Related news items


Prinses Beatrix Spierfonds grant to investigate patient stratification in myotonic dystrophy

24 January 2020

Rick Wansink and Roland Brock, both theme Nanomedicine, received a € 280,000 grant from the Prinses Beatrix Spierfonds.

read more

RIMLS PhD retreat registration is open

23 January 2020

Yearly, RIMLS PhD candidates gather for the two-day PhD Retreat. Apart from the science, this event is highly valued for the opportunity to meet and get to know fellow PhD candidates during the social activities. Early bird registration and abstract submission deadline: 4 March 2020.

read more

Cognitive behavioral therapy reduces severe fatigue in patients with advanced cancer during treatment

23 January 2020

In Annals of Oncology, RIHS researchers Hanneke Poort, Marlies Peters, Winette van der Graaf, Ria Nijhuis van der Sanden and colleagues showed significant effects of cognitive behavioral therapy on fatigue in patients with advanced cancer during treatment with palliative intent.

read more

6 million euros to uncover link between metabolic and brain disorders

21 January 2020

An important European-funded initiative, coordinated by Radboudumc researchers Barbara Franke, Jan Buitelaar, and Janita Bralten, has been launched to explore how common molecular mechanisms may link metabolic disorders with brain disorders.

read more

NWO Open Competition Domain Science - XS grant for Ronald van Rij and Jenny van der Wijst

21 January 2020

NWO Domain Science has awarded Ronald van Rij, theme Infectious diseases and global health and Jennny van der Wijst, theme Renal disorders an XS grant. The XS category emphatically strives to encourage curiosity-driven and bold research involving a relatively quick analysis of a promising idea.

read more

First BeNeFit funding granted for psoriasis

17 January 2020

RIHS researchers Elke de Jong and Juul van den Reek of Dermatology Radboudumc and Dermatology Ghent received a grant of 1.6 million euros for investigating dose reduction of the newest biologics for psoriasis.

read more